Point Of Care Lipid Test Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Point Of Care Lipid Test Market Size Likely To Evolve From 2025 Through 2034?

The point of care lipid test market has experienced significant growth in recent years. It is projected to increase from $0.68 billion in 2024 to $0.74 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.9%. This historical expansion can be attributed to the rising prevalence of cardiovascular disease and dyslipidemia, the development of multi-analyte and multiplex testing, augmented healthcare expenditure and reimbursement support, increased awareness and emphasis on preventive healthcare, and broader implementation in retail pharmacies, clinics, and community settings.

The point of care lipid test market size is anticipated to experience substantial expansion in the upcoming years, with projections indicating a rise to $1.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.5%. This growth over the forecast period is primarily driven by factors such as the increasing uptake in home-based and self-monitoring environments, heightened awareness and screening efforts for genetic lipid disorders, the escalating burden of chronic diseases, a shift towards value-based healthcare frameworks, and a consistent demand for consumables. Significant trends anticipated during this period include advancements in portable technology, integration with digital health systems, incorporation with remote patient monitoring (RPM) and telemedicine platforms, integration within IoMT or connected health infrastructure, and the adoption of edge computing and low-power biosensor chips.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28300&type=smp

Which Industry Drivers Are Expected To Accelerate The Point Of Care Lipid Test Market From 2025 To 2029?

The rising occurrence of cardiovascular conditions is projected to drive the expansion of the point of care lipid test market in the future. These diseases encompass ailments of the heart and blood vessels, such as coronary artery disease, stroke, and high blood pressure, frequently stemming from atherosclerosis associated with unusual cholesterol and triglyceride levels. The increasing incidence of cardiovascular diseases is attributed to the adoption of more sedentary lifestyles and decreased physical movement, factors that foster obesity, impaired circulation, and other contributors to CVDs. Point-of-care lipid tests aid in addressing the escalating prevalence of cardiovascular diseases by offering rapid, immediate measurement of cholesterol and other lipid concentrations, facilitating early detection of risks and swift therapeutic choices to halt disease advancement. For example, data from January 2024, released by the American Heart Association, a US-based nonprofit organization, indicated that within the cardiovascular sector, fatalities from cardiovascular disease reached 931,578, marking an increase of 3,000 fatalities from the prior year’s total of 928,741. Consequently, the growing occurrence of cardiovascular ailments is anticipated to drive the expansion of the point of care lipid test market.

What Are The Major Segments Identified In The Point Of Care Lipid Test Market?

The point of care lipid test market covered in this report is segmented as

1) By Product Types: Instruments, Consumables, Other Product Types

2) By Application: Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications

3) By End-User: Hospitals, Clinics, Diagnostic Laboratories, Home Care Settings, Other End Users

Subsegments:

1) By Instruments: Benchtop Analyzers, Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers

2) By Consumables: Test Strips, Reagents And Kits, Quality Control Materials, Calibrators

3) By Other Product Types: Software Solutions, Accessories, Data Management And Connectivity Tools

What Key Innovation Trends Are Fueling Advancements In The Point Of Care Lipid Test Market?

Major companies operating in the point-of-care lipid test market are concentrating on innovative solutions, including advanced point-of-care (POC) diagnostic platforms, to deliver rapid, accurate, and lab-quality lipid panel results at the patient’s bedside, which enhances clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform is a portable, integrated device that performs quick, accurate, and lab-quality tests near the patient, enabling real-time clinical decision-making and immediate health management. For instance, in July 2023, Vital Biosciences Inc., a Canada-based health technology company, unveiled VitalOne, a point-of-care lab testing platform engineered to provide over 50 lab-grade blood test results in just 20 minutes using a compact, automated device at locations such as clinics and pharmacies. This system integrates hematology, clinical chemistry, and immunoassays into a single instrument, empowering healthcare providers to perform testing, diagnosis, and treatment in one visit, thereby substantially improving access, speed, and personalization of patient care, all with accuracy comparable to traditional central labs.

Which Major Industry Participants Are Leading The Point Of Care Lipid Test Market Growth?

Major companies operating in the point of care lipid test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quidel Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, Fisher Scientific International Inc., Everlywell Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, VivaChek Biotech (Hangzhou) Co. Ltd., EuroMedix International NV, A. Menarini Industrie Farmaceutiche Riunite S.r.l., AccuBioTech Co. Ltd., Callegari S.r.l., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report

How Do Regional Market Performances Compare Within The Point Of Care Lipid Test Industry?

North America was the largest region in the point of care lipid test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care lipid test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Point Of Care Lipid Test Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28300&type=smp

Browse Through More Reports Similar to the Global Point Of Care Lipid Test Market 2025, By The Business Research Company

Lipid Panel Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Low Density Lipoprotein Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report

Lipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795